NCT00003958: Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma |
|
|
| Completed | 3 | 702 | US | dactinomycin, ACT-D, actinomycin C1, AD, Cosmegen, DACT, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, therapeutic conventional surgery, radiation therapy, irradiation, radiotherapy, therapy, radiation, topotecan hydrochloride, hycamptamine, Hycamtin, SKF S-104864-A, TOPO, filgrastim, G-CSF, Neupogen, sargramostim, GM-CSF, Leukine, Prokine, laboratory biomarker analysis | Children's Oncology Group, National Cancer Institute (NCI) | Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma | 10/07 | | | |
